Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Biolog Announces Appointment of Distributors in Europe

Published: Thursday, September 27, 2012
Last Updated: Thursday, September 27, 2012
Bookmark and Share
New distributors to cover sales and marketing of Biolog’s innovative product lines.

New distributors were announced by Biolog, Inc. to cover sales and marketing of its innovative product lines for characterization and identification of diverse cell types, from bacteria to human cells.

The distributors and their respective territories are IUL Instruments GmbH, Koningswinter, Germany (Germany and Austria), Awel International, Blain, France (France), A&LCO Industries, Cologno, Italy (Italy), and IUL S.A., Barcelona, Spain (Spain).

According to Barry Bochner, CEO & CSO at Biolog, "The distributors were selected as being most qualified to provide local supply, technical and service support to our customers in these countries."

Biolog's flagship product is the GEN III MicroPlate™, a test panel that can be used for identifying over 1,300 species of bacteria and covering human pathogens, animal pathogens, plant pathogens, and typical environmental bacteria.

Phenotype MicroArrays™, the company's most advanced product line, have diverse applications ranging from basic genetic and cellular research to cancer studies, drug and toxicology studies, and bioprocess optimization.

Biolog's product lines also include advanced instrumented systems such as the OmniLog® and MicroStation™ that automatically read and help to interpret the phenotypic data that is generated.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Biolog’s PM Technology Unlocks Critical Clue in Understanding Autism
Discovery demonstrates advantage of metabolic over genetic screening.
Friday, June 07, 2013
Scientific News
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Unique Model for Studying ALS
Unique mouse model will allow researchers to better study the genetic origins and potential treatments of ALS.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!